|
Table of Contents
November 2006 (Vol. 5, No. 11) Evidence-Based ReviewsIs this patient dangerous?
John Battaglia, MD Avoiding EPS is key to realizing ‘atypical’ benefits
Rajiv Tandon, MD; Robert J. Constantine, PhD The ‘meth’ epidemic: Managing acute psychosis, agitation, and suicide risk
J. Michael Bostwick, MD; Timothy W. Lineberry, MD Identifying hypothyroidism’s psychiatric presentations
Thomas D. Geracioti Jr, MD InterviewProtect yourself against patient assault From The EditorPathways of pleasure and pain: How well do you know dopamine?
Henry A. Nasrallah, MD Med/Psych UpdateHepatitis C: How to manage mood during interferon treatment
Kari A. Martin, MD; Lois E. Krahn, MD; Marianne J. Rosati, MSN, CRNP; Vijayan Balan, MD Cases That Test Your SkillsThe consequences of sipping ‘tea’
Melissa Buboltz, MD; Sahana Misra, MD; Linda Ganzini, MD, MPH Comments & ControversiesClonazepam versus buspirone Hail to the chief Prescription pad packs a punch Out Of The PipelinePaliperidone
George M. Simpson, MD Neuroscience NewsEye-opening behaviors help diagnose nonepileptic seizures
W. Curt LaFrance Jr, MD Psyber PsychiatryPDA prescription program pros and cons
Robert Boland, MD Pearls6 safety rules for tapering antidepressants
Richard C. Shelton, MD 10 tips for working with a drug formulary
Piyush Das, MBBS; Sriram Ramaswamy , MD; Subhash C. Bhatia, MD
Subscribe to Current Psychiatry
e-alert
|
